Skip to content

Insider · CIK 0001892819

Karen Marie Johnson

director

Files at STLN (Oncology Institute, Inc.). First filing Mar 28, 2025, latest Mar 28, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$38k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

STLN: Oncology Institute, Inc.

STLNOct 9, 2026 · close 6.63

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
42Moderate
STLNbuy 5
Oncology Institute, Inc.
$38k
36,224 shares
+22%+817% from low-4% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 26, 2025STLN
Oncology Institute, Inc.
POpen-market purchase
Common Stock
+36,224$1.04$38k203,409Mar 28, 2025
Mar 26, 2025STLN
Oncology Institute, Inc.
POpen-market purchase
Common Warrantderivative
+18,112$0.13$2,26418,112Mar 28, 2025
Nov 22, 2024STLN
Oncology Institute, Inc.
AGrant or award
Common stock
+52,000$0.00$0167,185Nov 25, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Karen Marie Johnson: insider trades and track record | InsiderTell